Watertime, Author at PsyNews.com

Home Authors Posts by Watertime

107 POSTS 0 COMMENTS

The Psilocybin Supply Chain: An Evidence-Based Review

Psygen Industries Ltd letter to Health Canada re: SAP

Experts Predict What 2021 Psychedelics Space Might Look Like

You Don’t Have to Take Psychedelics to Benefit from Them —...

Somerville, Massachusetts, Passes Measure to Decriminalize Psychedelics

123...11 Page 2 of 11

EDITOR PICKS

Standards, Ethics, and Integration: Rebuilding Trust in the Ketamine Industry

Psychedelic Investor Survey Q3 2024

Dispatch From the DEA: DOI and DOC on Trial As Scientists...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Watertime

November 2020 Newsletter

The Psilocybin Supply Chain: An Evidence-Based Review

July 2020 Newsletter

Psygen Industries Ltd letter to Health Canada re: SAP

Sept/Oct 2020 Newsletter

June 2020 Newsletter

CLINICAL RESEARCH ASSOCIATE